Pharmacological treatments aimed at managing osteoporosis, including but not limited to bisphosphonates, denosumab, selective estrogen receptor modulators (SERMs), teriparatide, or other osteoporosis medications. Studies involving combination therapy targeting both osteoporosis and diabetes mellitus outcomes were also considered. Here, ESR1 is linked to diabetes mellitus.